Literature DB >> 17099020

Pulmonary abnormalities on high-resolution CT demonstrate more rapid decline than FEV1 in adults with cystic fibrosis.

Eoin P Judge1, Jonathan D Dodd, James B Masterson, Charles G Gallagher.   

Abstract

BACKGROUND: FEV1 may remain stable while high-resolution CT (HRCT) appearances deteriorate in children with cystic fibrosis (CF). However, spirometry results commonly decline in older age groups.
OBJECTIVES: To compare the rate of decline in HRCT abnormalities and spirometry results over time in an adult cohort with CF.
METHODS: The HRCT scans of 39 consecutive patients (19 males and 20 females; mean age, 22 years; range, 16 to 48 years) with two HRCT scans > 18 months apart were randomly and blindly scored using a modified Bhalla scoring system by two independent chest radiologists. Age, body mass index, spirometry, and sputum cultures were recorded at the time of both HRCTs. Rates of change in clinical parameters and HRCT abnormalities were calculated and compared using repeated-measures analysis of variance.
RESULTS: Mean FEV1 declined at a rate of - 2.3% per year, while mean HRCT total score declined at a rate of -2.7% per year. Several individual HRCT abnormalities as well as HRCT total scores declined significantly faster than FEV1 (p < 0.001). Six patients showed stable spirometry results but worsening HRCT scores. Mucus plugging and extent of bronchiectasis deteriorated at a more rapid rate in the group with mildly impaired lung function. Air trapping, collapse/consolidation, peribronchial thickening, severity of bronchiectasis, and generations of bronchial divisions involved deteriorated at a more rapid rate in the group with moderate-to-severely impaired lung function.
CONCLUSIONS: Adult CF patients have more rapid rates of decline in HRCT abnormalities than in spirometry results. Individual HRCT abnormalities decline at different rates depending on the degree of lung function impairment.

Entities:  

Mesh:

Year:  2006        PMID: 17099020     DOI: 10.1378/chest.130.5.1424

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  19 in total

Review 1.  Advancing outcome measures for the new era of drug development in cystic fibrosis.

Authors:  Nicole Mayer-Hamblett; Bonnie W Ramsey; Richard A Kronmal
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

2.  Association of FANCC polymorphisms with FEV1 decline in aspirin exacerbated respiratory disease.

Authors:  Jeong-Hyun Kim; Byung-Lae Park; Charisse Flerida A Pasaje; Joon Seol Bae; Jong Sook Park; Sung Woo Park; Soo-Taek Uh; Jae-Sung Choi; Yong-Hoon Kim; Mi-Kyeong Kim; Inseon S Choi; Sang Heon Cho; Byoung Whui Choi; Choon-Sik Park; Hyoung Doo Shin
Journal:  Mol Biol Rep       Date:  2011-06-14       Impact factor: 2.316

3.  High-resolution CT of nontuberculous mycobacterium infection in adult CF patients: diagnostic accuracy.

Authors:  Sinead McEvoy; Lisa Lavelle; Aoife Kilcoyne; Colin McCarthy; Pim A deJong; Martine Loeve; Harm A W M Tiddens; Edward McKone; Charles G Gallagher; Jonathan D Dodd
Journal:  Eur Radiol       Date:  2012-07-20       Impact factor: 5.315

4.  Changes in structural lung disease in cystic fibrosis children over 4 years as evaluated by high-resolution computed tomography.

Authors:  Carlos Carpio; Gustavo Albi; José Carlos Rayón-Aledo; Rodolfo Álvarez-Sala; Rosa Girón; Concepción Prados; Paloma Caballero
Journal:  Eur Radiol       Date:  2015-05-01       Impact factor: 5.315

Review 5.  Computed tomography dose optimisation in cystic fibrosis: A review.

Authors:  Helena Ferris; Maria Twomey; Fiachra Moloney; Siobhan B O'Neill; Kevin Murphy; Owen J O'Connor; Michael Maher
Journal:  World J Radiol       Date:  2016-04-28

6.  Asthma and Hypogammaglobulinemia: an Asthma Phenotype with Low Type 2 Inflammation.

Authors:  Clairelyne Dupin; Sylvain Marchand-Adam; Olivier Favelle; Romain Costes; Philippe Gatault; Philippe Diot; Leslie Grammatico-Guillon; Laurent Guilleminault
Journal:  J Clin Immunol       Date:  2016-10-06       Impact factor: 8.317

7.  Phenotyping of chronic obstructive pulmonary disease using the modified Bhalla scoring system for high-resolution computed tomography.

Authors:  Baykal Tulek; Ali Sami Kivrak; Seda Ozbek; Fikret Kanat; Mecit Suerdem
Journal:  Can Respir J       Date:  2013 Mar-Apr       Impact factor: 2.409

8.  Development and validation of automated 2D-3D bronchial airway matching to track changes in regional bronchial morphology using serial low-dose chest CT scans in children with chronic lung disease.

Authors:  Pavithra Raman; Raghav Raman; Beverley Newman; Raman Venkatraman; Bhargav Raman; Terry E Robinson
Journal:  J Digit Imaging       Date:  2009-09-15       Impact factor: 4.056

9.  Chest CT abnormalities and quality of life: relationship in adult cystic fibrosis.

Authors:  Aoife Kilcoyne; Lisa P Lavelle; Colin J McCarthy; Sinead H McEvoy; Hannah Fleming; Annika Gallagher; Martine Loeve; Harm Tiddens; Edward McKone; Charles C Gallagher; Jonathan D Dodd
Journal:  Ann Transl Med       Date:  2016-03

10.  Lung diffusing capacity for nitric oxide and carbon monoxide in relation to morphological changes as assessed by computed tomography in patients with cystic fibrosis.

Authors:  Holger Dressel; Laura Filser; Rainald Fischer; Katharina Marten; Ullrich Müller-Lisse; Dorothea de la Motte; Dennis Nowak; Rudolf M Huber; Rudolf A Jörres
Journal:  BMC Pulm Med       Date:  2009-06-16       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.